Blog

Categories
  1. Donanemab in Switzerland: How to get the new Alzheimer's medicine now

    When will the newest Alzheimer's medicine be available to patients in Switzerland (and how to get it sooner)?

    Read more »
  2. Lecanemab in Switzerland: How to get the new Alzheimer's medicine now

    Is the new Alzheimer's medicine available to Swiss patients, and how can you get it?

    Read more »
  3. Olezarsen's EMA approval: When is the new medicine for lowering triglycerides coming to you?

    A new efficient and safe medicine to lower triglycerides in FCS patients is now available. But when will it be available to you?

    Read more »
  4. Rezdiffra and Weight Loss Medicines: Rivals or Partners in Treating MASH?

    Can Rezdiffra lead to weight loss and how can it be combined with weight loss medicines as part of your MASH treatment?

    Read more »
  5. What patients should know about ensifentrine, the newest medication for COPD

    All you should know about the newest treatment for COPD, including how it compares to other medicines.

    Read more »
  6. Resmetirom's approval in Europe and the UK: When will the MASH medicine be available?

    When will the first approved medicine for fatty liver with fibrosis be available in Europe and the UK?

    Read more »
  7. Ensifentrine's EMA approval: When will the newest inhaled COPD medicine be available in Europe?

    When will the new medicine for COPD be available to patients in Europe and the UK (and how not to wait)?

    Read more »
  8. Zolbetuximab for pancreatic cancer: Is approval expected soon?

    What are the latest clinical trial results for zolbetuximab in pancreatic cancer, and is approval expected soon?

    Read more »
  9. After zolbetuximab's EU approval: When will the medicine be available to patients?

    When will the first targeted therapy for CLDN 18.2-positive gastric and GEJ cancer be available to patients in Europe?

    Read more »
  10. Revumenib’s approval in Europe and beyond: When is the breakthrough treatment for leukemia coming to you?

    When will the first targeted therapy for acute leukemia with KMT2A translocation be available outside the USA?

    Read more »
  11. Miplyffa’s approval: How long until the first medicine for Niemann-Pick is available in your country?

    When will the first medicine for NPC be available to patients in Europe, the UK, and beyond (and how not to wait)?

    Read more »
  12. Ibudilast for ALS: When is FDA approval coming (and how not to wait)?

    When is Ketas (ibudilast) expected to be approved in the USA, EU, and more? And how can you start your ALS treatment in the meantime?

    Read more »
  13. Zanidatamab’s Approval for Biliary Tract Cancer: How Long Will You Have to Wait?

    When is the first targeted therapy for HER2-expressing BTC getting its approval? All about the timelines and your options in the meantime.

    Read more »
  14. Upcoming Alzheimer’s Medicines Currently in Development

    What are the current directions of Alzheimer's medicine research, and which medicines are promising?

    Read more »
  15. Remember There's More: Exploring New Options in Alzheimer's Treatment with Dr. Niels Prins

    An interview with Dr. Niels Prins from the Brain Research Center in Amsterdam about the future of Alzheimer's treatment.

    Read more »
  16. How to Participate in Alzheimer's Clinical Trials in The Netherlands

    How to find and participate in clinical trials in the Netherlands, as a way to support treatment development and access medicines not yet available locally.

    Read more »
  17. Is there a new medicine against Alzheimer’s [2024]?

    What are the newest medicines for Alzheimer's disease in Europe and the world?

    Read more »
  18. Can I take Leqembi together with Eliquis?

    Read more »
  19. How can you slow down Alzheimer’s disease? Some approaches to try.

    Which medicines and lifestyle changes can help slow down cognitive decline in Alzheimer's patients?

    Read more »
  20. Alzheimer’s treatments in the Netherlands: What is (not yet) available? [2024]

    Which medicines for Alzheimer's are available to Dutch patients (and which - not yet)?

    Read more »
  21. Kisqali for early breast cancer: Where is it available and how to get it now?

    Where is Kisqali (ribociclib) approved as an adjuvant treatment for early breast cancer (and how to get it if it's not yet in your country)?

    Read more »
  22. Nipocalimab's approval: When is the latest treatment for myasthenia gravis coming to you?

    When is the latest treatment for myasthenia gravis going to be available to patients around the world?

    Read more »
  23. Opzelura cream in India: How to get the new vitiligo treatment?

    How to get the new vitiligo ointment from a trusted supplier in India?

    Read more »
  24. Vimseltinib's approval worldwide: When is the new TGCT treatment coming to you?

    When is the new treatment for TGCT expected to get approval, and how long will you have to wait?

    Read more »
  25. Mirdametinib's approval worldwide: When is the new NF1 treatment coming to you?

    When is the new treatment for NF1 expected to get approval worldwide? Find out all you need to know about mirdametinib.

    Read more »
  26. Inavolisib for breast cancer: When is approval coming (from the FDA, EMA, and more)?

    When is the newest treatment for HR-positive, HER2-negative breast cancer expected to get FDA, EMA, MHRA approval, and more?

    Read more »
  27. Aumolertinib's approval (FDA, EMA, MHRA and more): How long will you have to wait?

    The newest NSCLC treatment is already approved in China. When will it get FDA, EMA, or MHRA approval (and how to get it earlier)?

    Read more »
  28. Promising ALS treatments to keep an eye on [2024 Update]

    Get to know the promising ALS treatments in advanced development stages, which may be available within 5 years.

    Read more »
  29. The latest early-stage research on ALS treatments [2024 Update]

    Find out the latest research on the ALS treatments of the future.

    Read more »
  30. Odronextamab's FDA approval: Why it failed and how to get the medicine anyway?

    Odronextamab may not have gotten FDA approval, but it's on its way to getting the EMA's green light. Here's what that means for you as a US patient.

    Read more »
Page
US United States 0